Siemens Medical Solutions Diagnostics Launches the DCA Vantage Analyzer for Point-of-care Diabetes Management

Tarrytown, New York (ots/PRNewswire) -

- Advanced Network-Ready Diabetes Analysis for Better Patient
Management

Siemens Medical Solutions Diagnostics
(www.siemens.com/diagnostics) today announced the launch of the DCA
Vantage(TM) Analyzer, a point-of-care (POC) diabetes patient
management platform providing glycosylated hemoglobin (HbA1c),
Microalbumin/Creatinine and Albumin-to-Creatinine tests for diabetes
management. The DCA Vantage Analyzer is critical for monitoring a
patient's glycemic control and helps physicians to encourage patient
compliance by delivering actionable test results during a patient
visit. The system delivers the simplicity and convenience required at
the point of care with no sample or reagent preparation steps. The
DCA Vantage Analyzer has been launched in Europe. The product is
pending FDA clearance and is not yet available for in vitro
diagnostic use in the US.

(Photo: http://www.newscom.com/cgi-bin/prnh/20070925/NYTU009 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"The DCA Vantage Analyzer builds on the proven technology and
performance of its predecessor, the DCA 2000+ while adding new
capabilities our customers need in their daily practice," said Arnd
Kaldowski, senior vice president, Point of Care Business, Siemens
Medical Solutions Diagnostics. "Siemens strives to continuously
deliver systems that provide tests with proven clinical benefit and
that fulfill the needs of our customers concerning ease of use and
data management in the point-of-care setting. We are confident that
this product solidifies our leadership position in point-of-care
diabetes testing and will help continue to drive testing closer to
the patient."

The DCA Vantage Analyzer enables clinicians to provide early
detection of kidney disease, the most common complication in patients
with diabetes. In addition, there is an onboard Glomerular filtration
rate (GFR) calculator to assist in kidney disease staging.

With the new DCA Vantage Analyzer, physicians can enter a patient
ID via touch screen or barcode, view the on-board printed reports and
HbA1c patient trending graphs, and easily download the patient
results to an external healthcare information technology (HIT)
system. For testing sites that require compliance and control of
decentralized testing, powerful features such as connectivity to LIS,
operator ID entry, QC reminders, test lock-out, remote access, and
adjustable correlation to reference methods are available. Other
unique features include the ability to adjust correlation parameters
in order to match reference assays or standardize results over
multiple systems.

The DCA Vantage Analyzer's flexible data management enhancements
and testing compliance capabilities help boost productivity by
providing speedy access to patient data. The system is network-ready
and test results can be shared within the office, clinic or among
coordinated POC sites. These benefits translate to the physician's
ability to have productive discussions with patients during their
visits and ability to positively impact everything from patient
compliance to treatment regimen.

Simple, convenient testing is enabled by an intuitive color touch
screen display. The operator loads the test cartridge which includes
the patient sample onto the system and walks away. The system
automatically performs the test procedure, stores the patient results
and displays, prints and/or uploads patient results to the LIS/HIS.
The DCA platform delivers proven performance documented in over 100
clinical articles and boosts clinical confidence.

About Siemens Medical Solutions Diagnostics

Siemens Medical Solutions Diagnostics offers a broad portfolio of
performance-driven diagnostic solutions that assist in the diagnosis,
monitoring and management of disease. The company's products and
services bring together the right balance of science, technology, and
practicality across the healthcare continuum to empower medical
professionals with the vital information they need to deliver better,
more personalized healthcare to patients around the globe. Visit
www.siemens.com/diagnostics.

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the
world's largest suppliers to the healthcare industry. The company is
known for bringing together innovative medical technologies,
healthcare information systems, management consulting, and support
services, to help customers achieve tangible, sustainable, clinical
and financial outcomes. Recent acquisitions in the area of in-vitro
diagnostics - such as Diagnostic Products Corporation and Bayer
Diagnostics - mark a significant milestone for Siemens as it becomes
the first full service diagnostics company. Employing more than
41,000 people worldwide and operating in over 130 countries, Siemens
Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33
billion EUR and group profit of 1.06 billion EUR for fiscal 2006
(Sept. 30). Further information can be found by visiting
www.usa.siemens.com/medical-pressroom.

Web site: http://www.usa.siemens.com/medical
http://www.usa.siemens.com/medical-pressroom
http://www.siemens.com/diagnostics

ots Originaltext: Siemens Medical Solutions Diagnostics
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Amanda Naiman of Siemens Medical Solutions, +1-610-448-4531,
amanda.naiman@siemens.com ; Photo: NewsCom:
http://www.newscom.com/cgi-bin/prnh/20070925/NYTU009,
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO , AP
Archive: http://photoarchive.ap.org , PRN Photo Desk,
photodesk@prnewswire.com/